CPhI Korea is a pivotal event designed for pharmaceutical suppliers, purchasers, and decision-makers, serving as the core of Korea's Pharma & Bio Innovation. This dynamic meeting place showcases products across the entire pharmaceutical supply chain, including ingredients, contract services, machinery, and biopharmaceuticals. Exhibitors gain access to exceptional growth opportunities, global brand awareness, and high-quality lead generation, connecting with global leaders and experts. Attendees can explore the latest breakthroughs in drug development, API manufacturing, and packaging technologies through cutting-edge exhibits and a high-level conference. With a focus on real reviews, results, and ROI, CPhI Korea is essential for expanding business horizons and understanding Korea's evolving pharma market.
Highlights
4 items
01
Comprehensive Pharma Supply Chain Showcase
Explore products across the entire pharma supply chain, including ingredients, contract services, machinery, and biopharmaceuticals.
02
Strong Industry Participation
Past editions hosted over 175 exhibitors and attracted more than 5,000 executives from 50 countries.
03
Exceptional Business Growth Opportunities
Exhibitors gain global brand awareness, high-quality lead generation, and access to the global supply chain.
04
Insightful Conference & Networking
Features a high-level conference on Korea's pharma market and 1:1 Business Matchmaking programs.
FAQ
5 questions
CPhI Korea is a dynamic meeting place for pharmaceutical suppliers, purchasers, and decision-makers, serving as the heart of Korea's Pharma & Bio Innovation.
The exhibition covers the entire pharma supply chain, including ingredients, contract services, machinery, and biopharmaceuticals.
The target audience includes pharmaceutical suppliers, purchasers, decision-makers, global leaders, and experts across the pharma supply chain.
The event facilitates connections with global leaders and experts, and past editions included a 1:1 Business Matchmaking Programme.
Attendees can gain in-depth insight into Korea's pharma market through a high-level conference, covering trends, challenges, and opportunities.
